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Monday, February 17, 2014 301aformation (71VTGVTAVAQKTV82). In the present study, we have investi-
gated the membrane interactions of this 12-mer peptide using 31P solid-state
NMR spectroscopy as well as infrared spectroscopy while the peptide structure
was studied by infrared spectroscopy. The phospholipids used have different
acyl chain lengths and different polar headgroups. The results show that the
peptide tends to aggregate and specifically interacts with the negatively charged
membranes.
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The association of the 99 residue transmembrane C-terminal domain (C99) of
the amyloid precursor protein with cholesterol-rich membrane domains (‘‘lipid
rafts’’) is thought to promote cleavage of C99 to release the Alzheimer’s
disease-promoting amyloid-b (Ab) polypeptide. Here, we test the hypothesis
that C99 has an intrinsic affinity for raft-like liquid ordered (Lo) domains
and that its domain preference is regulated by cholesterol binding. Fluorescence
microscopy shows that C99 undergoes efficient partitioning into Lo domains
relative to the co-existing liquid disordered (Ld) phase in giant unilamellar ves-
icles, establishing C99 as the transmembrane protein with the highest affinity
for Lo domains known to date. Lo partitioning is prevented upon mutating res-
idues that are critical for cholesterol binding to C99, indicating that binding of
this sterol is a critical determinant of the phase preference of the protein. Addi-
tion of coprostanol, a raft-breaking sterol that can compete with cholesterol for
binding to C99, shifts partitioning away from the Lo phase. These findings
identify cholesterol binding as a novel mechanism that controls the raft target-
ing of C99 and suggest that pharmacological inhibition of this process could
potentially be exploited as a therapeutic approach to avoid or treat Alzheimer’s
disease.
1534-Pos Board B264
How Do Lipids Localize in Lewy Bodies?
Himanshu Chaudhary1, Vinod Subramaniam2,1, Mireille Claessens1.
1Science and Technology, University of Twente, Enschede, Netherlands,
2Nanoscale Biophysics, FOM Institute AMOLF, Amsterdam, Netherlands.
Lewy bodies are the pathological hallmark of Parkinson’s disease (PD). While
fibrillar a-synuclein (aS) is the main protein component of Lewy bodies, these
structures also contain lipids. To elucidate the presence of lipids in Lewy
bodies, we investigated the interaction of lipids with monomeric and fibrillar
aS. In vitro, lipid membranes accelerated aS fibril formation under physiolog-
ical conditions. Moreover lipids and small vesicles co-localized with supra-
fibrillar structures and individual aS fibrils suggesting that aggregation initiates
at the membrane. The presence of lipids in Lewy bodies may therefore be an
indication that cell membranes are the major target in aggregation induced
neuronal cell death.
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The interaction between lipid bilayers and amyloid beta-peptide (Ab) is of
great interest in understanding Alzheimer’s disease (AD). Accumulating ev-
idence points to a positive association of cholesterol in the membrane and
AD, but a molecular-level interaction between cholesterol and Ab has not
been established. As an essential part of the membrane, cholesterol enhances
the fluidity of the lipid bilayer, which may reduce membrane permeation
caused by Ab, potentially alleviating its ability to rupture the membrane.
On the other hand, cholesterol increases the binding affinity of Ab to model
lipid membranes, as Ab shows little affinity to cholesterol-free membranes.
We studied the Ab conformations change in a model lipid membrane of
DMPC/DMPG/cholesterol by circular dichroism, isothermal titration calorim-
etry and fluorescence. The structural changes in lipid bilayers caused by Ab
was studied by grazing angle neutron diffraction (GAND) on multilamellar
lipid membrane samples in conjunction with solution Small-Angle Neutron
Scattering (SANS) on lipid vesicles. The experiments combine to provide
new molecular level details about how cholesterol and Ab interact in the lipid
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Pathological accumulation of a-synuclein (a-syn) is a feature of Parkinson’s
disease. This accumulation may be counteracted by mechanisms of protein
degradation that involve the proteasome and lysosome. Specifically, the lyso-
somal protease, Cathepsin D (CatD), has been suggested to be the main enzyme
involved in the degradation of a-syn in vivo. In vitro, only C-terminal truncated
species are generated, arguing that other mechanisms are needed to fully
explain a-syn degradation. Here, we show that N-terminally acetylated a-syn
also generates C-terminal as well as N-terminal truncated variants in the pres-
ence of CatD. These species are shown to be more aggregation prone. Since a-
syn associates with membranes, we have investigated the effects of various gly-
cosphingolipids such as glucosylceramide (GlcCer), on CatD degradation of a-
syn. It is known that GlcCer buildup is a hallmark of the lysosomal storage dis-
order Gaucher disease and that these patients have an increased risk of devel-
oping PD. Our data clearly shows that in the presence of GlcCer and CatD, a-
syn is completely proteolyzed. These data offer new mechanistic insight into a-
syn degradation in the lysosome.
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Fibrinogen and Alpha 1-Antitrypsin (A1AT) are plasma glycoproteins with
different, but specific functions. A1AT has been shown to have protective roles
of lung cells against emphysema, a disease characterized by lung tissue destruc-
tion [1], while fibrinogen is a major factor in the blood clotting process. Most
known glycoproteins have been shown to play a role in cellular interactions but
the exact role of the glycan chains is still under investigation. Previous electro-
physiological measurements show that A1AT has a strong affinity to lipid bi-
layers perturbing the function of ion channels present in the membrane. This
study was designed to investigate how protein-membrane and protein-protein
interactions affect the native conformation of the protein and membrane in
question. Two different glycoproteins were used for comparison purposes.
For A1AT, we performed contrast-matching small-angle neutron scattering
(SANS) and small angle x-ray scattering (SAXS) experiments to study the
structural changes of the glycosylated form of A1AT in the presence of three
different lipid membranes: POPC, POPS and DLPC. For fibrinogen, we per-
formed dynamic light scattering (DLS) measurements to find a suitable protein
concentration that would yield the reaction rate needed for a time resolved
SANS study of the structural evolution of fibrinogen polymerization in solu-
tion. Guinier fits were used as a first approximation to obtain the radius of gy-
ration (Rg) of A1AT, fibrinogen and fibrin. Pair distribution functions were
used to monitor the shifts in structural parameters and Bragg peaks were
used to study the structural changes of lipid vesicles. We observed that the
A1AT interacts with unilamellar vesicles and that fibrin structure is affected
by its polymerization rate. [1] Petrusca, et al., JBC 2010.
1538-Pos Board B268
Novel Properties of the Smurf1 C2 Domain in Cellular Lipid Binding
Jordan L. Scott1, Robert V. Stahelin2,1.
1Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN,
USA, 2Biochemistry and Molecular Biology, Indiana University School of
Medicine, South Bend, IN, USA.
Ubiquitin ligases are essential regulators of cellular homeostasis and have been
shown to contribute to cancer metastasis and new virus formation. The Nedd4
family of E3 ubiquitin ligases target a number of cellular substrates including
regulators involved in TGFb growth signaling and cellular motility. This 9-
member family of ubiquitin ligases has WW domains for target recognition
and C-terminal HECT catalytic domains for the covalent linkage of ubiquitin
to substrates. In addition, these proteins have N-terminal C2 domains that
bind lipids and enable them to localize to membranes.
We have discovered new properties of the C2 domain of the Nedd4 family
member Smurf1. The Smurf1 C2 domain acts as both a specific
phospholipid-binding protein and as an anionic charge sensor in vitro and in
